310 results

• FDA Warns of Revatio Risks for Children with Pulmonary Hypertension

  September 4, 2012

  Martha Garcia

  Federal health officials indicate that side effects of Revatio may pose an increased risk of death for children when the...

• Adalat, Nifediac, and Cordipin Increase Lip Cancer Risk: Study

  August 7, 2012

  Martha Garcia

  A new study suggests that there may be a link between a risk of lip cancer and certain drugs designed...

• Edarbi Should Not Be Used to Lower Blood Pressure, Group Warns

  July 6, 2012

  Ricky Allen

  The prominent consumer advocacy group Public Citizen is warning that the blood pressure medication Edarbi should not be used, as...

• Benicar Side Effects Linked to Celiac Disease Symptoms: Study

  July 5, 2012

  Ricky Allen

  The hypertension drug Benicar has been linked to a number of reports involving serious gastrointestinal side effects, producing symptoms typically...

• Sports Performance Drink Makers Get FDA Warning Calling for Recall

  May 1, 2012

  Staff Writers

  Federal health regulators have issued warnings to ten companies that manufacture sports performance drinks, indicating that they are failing to...

• Combination of Tekturna, Other Hypertension Drugs Gets FDA Warning

  April 23, 2012

  Staff Writers

  Federal health officials warn that the blood pressure drug Tekturna and similar medications should not be given to diabetics or...

• Antidepressant Pregnancy Risks Include High Blood Pressure: Study

  March 23, 2012

  Staff Writers

  The use of a popular class of antidepressants, which includes Paxil, Prozac and Zoloft, could put pregnant women at risk...

• Walgreens Medication Error Lawsuit Filed For Wrongful Death

  February 23, 2012

  Staff Writers

  A wrongful death lawsuit has been filed against Walgreens over an alleged medication error that killed a Kentucky woman. 

• Tekturna Kidney Damage Warning Added to Labels in Europe

  February 21, 2012

  Staff Writers

  European drug regulators are calling for new kidney damage warnings for Tekturna and other drugs containing the active ingredient aliskiren. 

• Tekturna Problems Lead to Trial Cancellation, Safety Review

  December 23, 2011

  Staff Writers

  Potential concerns about side effects of Tekturna, a blood pressure drug sold by Novartis, have surfaced after clinical trials were...